Bladder carcinoma in situ
MONDO:0004703Also known as carcinoma in situ of the urinary bladder or high grade intraurothelial neoplasia, this is a flat lesion of the transitional cell epithelium characterized by severe cytologic atypia. This lesion is confined to the urothelium, and is a precursor of invasive transitional cell carcinoma of the bladder. Stage 0is includes: Tis, N0, M0. Tis: Carcinoma in situ: "flat tumor". N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 6th and 7th eds.)
Also known as: cancer in situ of urinary bladder, bladder flat CIS, bladder flat carcinoma in situ, carcinoma in situ of bladder, carcinoma in situ of the urinary bladder, carcinoma in situ of urinary bladder, flat CIS of the bladder, flat CIS of the urinary bladder
2807 clinical trials for this condition and its sub-types, 30 tagged with Bladder carcinoma in situ itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →-
New bladder cancer drug shows early promise in small trial
Disease control CompletedThis early-phase trial tested a new drug called UGN-301 (zalifrelimab) given directly into the bladder for people with recurrent non-muscle invasive bladder cancer. The study included 51 participants and aimed to check safety and find the right dose, both alone and with other dru…
Phase 1 • Sponsor: UroGen Pharma Ltd. • Aim: Disease control
Last updated Jun 27, 2026 08:11 UTC
-
Smart devices track cancer recovery at home
Knowledge-focused CompletedThis study tested whether using at-home monitoring devices (like a wristband pedometer, scale, and blood pressure cuff) can help improve care for cancer patients after they leave the hospital following surgery. 22 patients with various cancers participated. The goal was to see if…
Sponsor: City of Hope Medical Center • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:02 UTC